Skip to main content

Table 4 Association between patient factors and pathogen frequencies

From: Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis

Univariate analysis

   

Enterococcus spp.

Enterobacterales

3GCRE

MRGN

P. aeruginosa

  

n

 

p-value

 

p-value

 

p-value

 

p-value

 

p-value

Age

< 65y

180

57.8%

0.664

48.3%

0.134

11.2%

0.621

9.0%

0.592

5.6%

0.823

> = 65y

168

60.1%

56.5%

13.5%

10.8%

6.5%

Sex

m

222

58.6%

0.910

53.2%

0.738

15.6%

0.016

13.3%

0.008

7.2%

0.252

f

126

59.5%

50.8%

6.5%

4.0%

4.0%

Charlson Index

< 5

201

53.7%

0.027

50.2%

0.384

8.6%

0.019

7.5%

0.100

5.0%

0.366

> = 5

146

65.8%

55.5%

17.4%

13.2%

7.5%

MDR carrier

no

289

57.8%

0.386

51.6%

0.570

9.1%

≤0.001

7.3%

≤0.001

5.2%

0.224

yes

59

64.4%

55.9%

28.1%

22.8%

10.2%

Time of bile collection from admission

≤ 48 h

153

59.5%

1.000

69.3%

≤ 0.001

13.9%

0.509

7.2%

0.147

4.6%

0.488

>  48 h

190

58.9%

38.9%

11.3%

12.3%

6.8%

Route of bile collection

endoscopic

203

56.7%

0.438

60.1%

≤ 0,001

11.0%

0.402

6.0%

0.003

5.4%

0.648

percutaneous

141

61.0%

42.6%

14.5%

15.8%

7.1%

ICUa

no

226

59.7%

0.732

63.3%

≤ 0.001

14.0%

0.228

8.9%

0.451

3.1%

0.002

yes

122

57.4%

32.0%

9.1%

11.7%

11.5%

Antibiotic pre-treatmentb

no

157

52.5%

0.006

56.3%

0.372

13.0%

1.000

7.0%

0.179

4.4%

0.345

yes

160

67.9%

51.2%

12.4%

11.9%

7.4%

Prior biliary tract intervention

no

64

42.2%

0.003

46.9%

0.406

4.8%

0.054

3.2%

0.059

4.7%

0.777

yes

282

63.1%

53.5%

14.1%

11.5%

6.4%

Indwelling biliary tract drainage

no

143

43.4%

≤ 0.001

51.7%

0.913

7.8%

0.044

7.1%

0.198

5.6%

0.823

yes

205

69.8%

52.7%

15.4%

11.8%

6.3%

Stenosis

no

161

50.9%

0.006

47.8%

0.133

8.2%

0.033

5.7%

0.018

5.0%

0.503

yes

187

65.8%

56.1%

15.8%

13.4%

7.0%

Biliodigestive anastomosis

no

248

59.5%

0.803

57.5%

≤ 0.001

11.5%

0.586

7.7%

0.044

5.6%

0.804

yes

100

57.3%

37.1%

14.1%

15.3%

7.0%

Liver transplantation

no

302

60.3%

0.201

56.6%

≤ 0.001

12.8%

0.628

9.7%

0.788

6.6%

0.333

yes

46

50.0%

23.9%

8.7%

11.1%

2.2%

Multivariate analysis - independent predictors

 

OR (95% CI)

p-value

       

Enterococcus spp.

 Indwelling biliary tract drainage

3.11 (1.94–5.00)

≤ 0.001

       

Enterobacterales

 Bile collection > 48 h from admission

0.41 (0.25–0.66)

≤ 0.001

       

 ICUa

0.38 (0.23–0.63)

≤ 0.001

       

3GCRE

 Male sex

2.61 (1.15–5.95)

0.022

       

 Charlson Index ≥5

1.98 (1.00–3.92)

0.049

       

 MDR carrier

3.57 (1.73–7.37)

≤ 0.001

       

MRGN

 Male sex

4.27 (1.42–12.82)

0.010

       

 MDR carrier

2.47 (1.04–5.86)

0.040

       

 Percutaneous bile collection

2.61 (1.13–6.01)

0.024

       

 Stenosis

2.66 (1,02-6,95)

0.046

       

P. aeruginosa

 ICUa

4.06 (1.59–10.34)

0.003

       
  1. MRGN, multidrug resistant gram negative bacteria as defined by KRINKO [6]
  2. MDR, multi-drug resistant bacteria including MRSA, MRGN, and VRE
  3. aICU, defined as treatment on ICU before or during bile sampling
  4. bAntibiotic pre-treatment within 3 months prior to admisson